Correlation Between Pharmicell and RFTech
Can any of the company-specific risk be diversified away by investing in both Pharmicell and RFTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmicell and RFTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmicell and RFTech Co, you can compare the effects of market volatilities on Pharmicell and RFTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmicell with a short position of RFTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmicell and RFTech.
Diversification Opportunities for Pharmicell and RFTech
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Pharmicell and RFTech is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pharmicell and RFTech Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RFTech and Pharmicell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmicell are associated (or correlated) with RFTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RFTech has no effect on the direction of Pharmicell i.e., Pharmicell and RFTech go up and down completely randomly.
Pair Corralation between Pharmicell and RFTech
If you would invest 304,000 in RFTech Co on October 24, 2024 and sell it today you would earn a total of 55,500 from holding RFTech Co or generate 18.26% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 1.61% |
Values | Daily Returns |
Pharmicell vs. RFTech Co
Performance |
Timeline |
Pharmicell |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
RFTech |
Pharmicell and RFTech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pharmicell and RFTech
The main advantage of trading using opposite Pharmicell and RFTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmicell position performs unexpectedly, RFTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RFTech will offset losses from the drop in RFTech's long position.Pharmicell vs. Taegu Broadcasting | Pharmicell vs. Alton Sports CoLtd | Pharmicell vs. PlayD Co | Pharmicell vs. SAMG Entertainment Co |
RFTech vs. Daeduck Electronics Co | RFTech vs. KyungIn Electronics Co | RFTech vs. SeAH Besteel Corp | RFTech vs. Korea Electronic Certification |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |